IAG regimen for patients with refractory/relapsed acute myeloid leukemia.
10.3760/cma.j.issn.0253-2727.2013.07.020
- Author:
Yong YANG
1
;
Cheng-fu JI
;
Yan-ming ZHANG
;
Li-Min LIU
;
Guang-sheng HE
;
Zheng-ming JIN
;
Xiao MA
;
Sheng-li XUE
;
Xue-feng HE
;
De-pei WU
;
Ai-ning SUN
Author Information
1. Key Laboratory of Thrombosis and Haemostasis, Ministry of Health, Jiangsu Institute of Hematology, Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Cytarabine;
administration & dosage;
Daunorubicin;
administration & dosage;
Female;
Humans;
Leukemia, Myeloid, Acute;
drug therapy;
Male;
Middle Aged;
Young Adult
- From:
Chinese Journal of Hematology
2013;34(7):637-638
- CountryChina
- Language:Chinese